Position in MEDP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$21,024,723
New position
Shares Held
39,700
first reported quarter
Ownership
0.142%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#83
of 691 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ING GROEP NV holds $198,923,237 across 9 Diagnostics & Research names. MEDP ranks #3 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
173,991 | $87,232,127 | |
| 2 | DHR |
Danaher Corp /De/
|
396,449 | $75,515,605 | |
| 3 | MEDP |
Medpace Holdings, Inc.
This page
|
39,700 | $21,024,723 | |
| 4 | A |
Agilent Technologies, Inc.
|
34,746 | $4,615,311 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
20,522 | $3,965,260 | |
| 6 | DGX |
Quest Diagnostics Inc
|
17,294 | $3,665,463 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
5,922 | $1,343,050 | |
| 8 | WAT |
Waters Corp /De/
|
2,154 | $807,836 |
All Filings in MEDP
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,024,723 | 39,700 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||